Axonics Inc (AXNX)
66.59
0.00 (0.00%)
USD |
NASDAQ |
May 01, 10:13
Axonics Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.0002 |
| June 30, 2021 | 0.0002 |
| March 31, 2021 | 0.2278 |
| December 31, 2020 | 0.0735 |
| Date | Value |
|---|---|
| September 30, 2020 | 0.0712 |
| June 30, 2020 | 0.0697 |
| March 31, 2020 | 0.1193 |
| December 31, 2019 | 0.1111 |
| September 30, 2019 | 0.2183 |
| June 30, 2019 | 0.1739 |
| March 31, 2019 | 0.1495 |
| December 31, 2018 | 0.1358 |
| September 30, 2018 | -0.1019 |
| June 30, 2018 | -0.1104 |
| March 31, 2018 | |
| December 31, 2017 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2021
0.2278
Maximum
Mar 2021
0.0561
Average
0.0002
Median
Jun 2021
Debt to Equity Ratio Benchmarks
| Boston Scientific Corp | 0.4718 |
| Cutera Inc | -2.620 |
| Stereotaxis Inc | 0.00 |
| Electromed Inc | 0.00 |
| Myomo Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 719.92M |
| Total Liabilities (Quarterly) | 82.36M |
| Shareholders Equity (Quarterly) | 637.56M |
| Current Ratio | 10.73 |